Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
Public ClinicalTrials.gov record NCT02268214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if adding dapagliflozin to insulin is a safe and effective therapy to improve glycemic control in patients with type 1 diabetes.
Study identification
- NCT ID
- NCT02268214
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 833 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 11, 2014 (Actual)
- Primary completion
- Jan 4, 2017 (Actual)
- Completion
- Aug 25, 2017 (Actual)
- Last update posted
- Sep 13, 2018
2014 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 20
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Little Rock | Arkansas | 72205 | — |
| Research Site | Encino | California | 91436 | — |
| Research Site | La Mesa | California | 91942 | — |
| Research Site | San Diego | California | 92161 | — |
| Research Site | Tarzana | California | 91356 | — |
| Research Site | Torrance | California | 90502 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Denver | Colorado | 80220 | — |
| Research Site | Cooper City | Florida | 33024 | — |
| Research Site | Jacksonville | Florida | 32258 | — |
| Research Site | Miami | Florida | 33136 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | Idaho Falls | Idaho | 83404-7596 | — |
| Research Site | Des Moines | Iowa | 50314 | — |
| Research Site | Louisville | Kentucky | 40213 | — |
| Research Site | Portland | Maine | 04101 | — |
| Research Site | Hyattsville | Maryland | 20782 | — |
| Research Site | Rockville | Maryland | 20852 | — |
| Research Site | Kalamazoo | Michigan | 49008 | — |
| Research Site | Minneapolis | Minnesota | 55416 | — |
| Research Site | Chesterfield | Missouri | 63017 | — |
| Research Site | Las Vegas | Nevada | 89148 | — |
| Research Site | Albany | New York | 12206 | — |
| Research Site | Buffalo | New York | 14215 | — |
| Research Site | Asheville | North Carolina | 28803 | — |
| Research Site | Chapel Hill | North Carolina | 27517 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Langhorne | Pennsylvania | 19047 | — |
| Research Site | Kingsport | Tennessee | 37660 | — |
| Research Site | Nashville | Tennessee | 37212 | — |
| Research Site | Amarillo | Texas | 79106 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Houston | Texas | 77090 | — |
| Research Site | Salt Lake City | Utah | 84108 | — |
| Research Site | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02268214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2018 · Synced Oct 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02268214 live on ClinicalTrials.gov.